Altium Capital Management LP Pro Qr Therapeutics N.V. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Altium Capital Management LP holds 575,000 shares of PRQR stock, worth $1.52 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
575,000Holding current value
$1.52 Million% of portfolio
0.52%Shares
3 transactions
Others Institutions Holding PRQR
# of Institutions
82Shares Held
45.1MCall Options Held
31.4KPut Options Held
24.7K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$25.4 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$13.2 Million3.12% of portfolio
-
Woodline Partners LP San Francisco, CA3.56MShares$9.43 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$7.49 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$7.49 Million1.38% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $189M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...